Decompression and curettage for the management of conventional follicular ameloblastoma in a pediatric patient: A case report.
Published 2026-07-07
Keywords
- ameloblastoma,
- Odontogenic tumors,
- Conservative treatment,
- Pediatrics,
- Case report
Downloads
How to Cite
Copyright (c) 2026 Juan José Guifarro, Selvin A. Flores, Claudette Arambú, Diego Zapata

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Abstract
Abstract:
Conventional follicular ameloblastoma is a locally aggressive benign odontogenic neoplasm whose occurrence in pediatric patients is uncommon and represents a considerable therapeutic challenge, given its potential impact on developing bone and dentition. We report the case of a 10-year-old male patient who presented with a six-month history of progressive facial swelling and asymmetry, accompanied by pain and paresthesia of the lower lip. Imaging evaluation by panoramic radiography revealed a well-defined unilocular radiolucent lesion associated with displacement of teeth 4.7 and 4.8, involving the right mandibular ramus and body. The definitive diagnosis was established through incisional biopsy, confirming a conventional ameloblastoma with a follicular pattern. The therapeutic approach initially consisted of decompression via intraoral tube drainage, followed by enucleation and curettage of the lesion, preserving the integrity of the developing mandibular bone.During a 14-month postoperative follow-up, radiographic assessment demonstrated progressive bone neoformation, with no evidence of recurrence or associated complications, and a favorable clinical outcome. This case suggests that conservative management represents an effective, low-morbidity therapeutic alternative in the treatment of conventional follicular mandibular ameloblastoma in pediatric patients, contributing to the existing evidence on this neoplasm in the pediatric population.
References
- Effiom OA, Ogundana OM, Akinshipo AO, Akintoye SO. Ameloblastoma: current etiopathological concepts and management. Oral Dis. 2018;24(3):307-316. doi:10.1111/odi.12646
- Hendra FN, Van Cann EM, Helder MN, Ruslin M, De Visscher JG, Forouzanfar T, et al. Global incidence and profile of ameloblastoma: a systematic review and meta-analysis. Oral Dis. 2020;26(1):12-21. doi:10.1111/odi.13031
- WHO Classification of Tumours Editorial Board. Head and neck tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2024. (WHO classification of tumours series, vol. 9).
- Soluk-Tekkeşin M, Wright JM. The World Health Organization classification of odontogenic lesions: a summary of the changes of the 2022 (5th) edition. Turk Patoloji Derg. 2022;38(3):168-184. doi:10.5146/tjpath.2022.01573
- Zhang J, Gu Z, Jiang L, Zhao J, Tian M, Zhou J, et al. Ameloblastoma in children and adolescents. Br J Oral Maxillofac Surg. 2010;48(7):549-554. doi:10.1016/j.bjoms.2009.08.020
- Emmerling MR, Wilken N, Dyalram D, Caccamese J, Ord R. Pediatric ameloblastoma: an update on 28 years of experience. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;131(4):e142. doi:10.1016/j.oooo.2020.12.029
- Bansal S, Desai RS, Shirsat P, Prasad P, Karjodkar F, Andrade N. The occurrence and pattern of ameloblastoma in children and adolescents: an Indian institutional study of 41 years and review of the literature. Int J Oral Maxillofac Surg. 2015;44(6):725-731. doi:10.1016/ j.ijom.2015.01.002
- Qiao X, Shi J, Liu J, Liu J, Guo Y, Zhong M. Recurrence rates of intraosseous ameloblastoma cases with conservative or aggressive treatment: a systematic review and meta-analysis. Front Oncol. 2021;11:647200. doi:10.3389/fonc.2021.647200
- Inthong P, Upalananda W, Saepoo J. Factors associated with recurrence of ameloblastoma: a scoping review. Head Neck Pathol. 2024;18(1):82. doi:10.1007/s12105-024-01686-7
- Gasparro R, Giordano F, Campana MD, Aliberti A, Landolfo E, Dolce P, et al. The effect of conservative vs. radical treatment of ameloblastoma on recurrence rate and quality of life: an umbrella review. J Clin Med. 2024;13(17):5339. doi:10.3390/jcm13175339
- Hendra FN, Helder MN, Ruslin M, Van Cann EM, Forouzanfar T. A network meta-analysis assessing the effectiveness of various radical and conservative surgical approaches regarding recurrence in treating solid/multicystic ameloblastomas. Sci Rep. 2023;13(1):8445. doi:10.1038/s41598-023-32190-7
- Xiong X, Li C, Guo L, Wu Y, Wang Y, Song X. Effect of intracapsular pressure on decompression effectiveness. Int Dent J. 2022;72(6):839-846. doi:10.1016/j.identj.2022.06.023
- Xu Y, Fu XJ, Xiang L, Li WS. Ameloblastoma in Chongqing children and adolescents: a review of 16 cases. J Stomatol Oral Maxillofac Surg. 2025; 126:102687. doi: 10.1016/j.jormas.2025.102687
- Wu K, Luo H, Yuan Z, Wang Y, Qin X, He J. Clinical evaluation of fenestration decompression combined with secondary curettage for ameloblastoma of the jaw: retrospective radiographic analysis. BMC Oral Health. 2022;22(1):443. doi:10.1186/s12903-022-02474-x
- Martins-de-Barros AV, Silva CCG, Gonçalves KKN, Almeida RAC, Silva EDO, Araújo FAC, ¿et al. Does BRAF V600E mutation affect recurrence rate of ameloblastomas? Systematic review and meta-analysis. J Oral Pathol Med. 2023;52(8):701-709. doi:10.1111/ jop.13458
- Mamat, Yusof MN, Ch'ng ES, Abdul Rahman NR. BRAF V600E mutation in ameloblastoma: a systematic review and meta-analysis. Cancers (Basel). 2022;14(22):5593. doi:10.3390/cancers14225593
